Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:activities |
gptkb:physicist
|
| gptkbp:appointed_by |
subcutaneous injection
|
| gptkbp:approves |
gptkb:2014
gptkb:FDA |
| gptkbp:brand |
gptkb:Saxenda
|
| gptkbp:clinical_trial |
Phase 3
chronic weight management SCALE Cardiovascular Outcomes Study SCALE Diabetes Study SCALE Maintenance Study SCALE Obesity and Prediabetes Study SCALE Sleep Apnea Study |
| gptkbp:contraindication |
gptkb:multiple_endocrine_neoplasia_syndrome_type_2
gptkb:medullary_thyroid_carcinoma |
| gptkbp:diet |
up to 10% body weight
lifestyle changes recommended |
| gptkbp:dosage_form |
injection
|
| gptkbp:duration |
as long as needed
|
| gptkbp:education |
storage instructions
recognizing side effects proper injection technique when to seek medical help importance of diet and exercise |
| gptkbp:frequency |
once daily
|
| https://www.w3.org/2000/01/rdf-schema#label |
Saxenda
|
| gptkbp:indication |
obesity treatment
|
| gptkbp:ingredients |
gptkb:liraglutide
|
| gptkbp:is_available_on |
pre-filled syringe
pen injector |
| gptkbp:is_monitored_by |
required
|
| gptkbp:is_used_for |
weight management
|
| gptkbp:manufacturer |
gptkb:Novo_Nordisk
|
| gptkbp:marketed_as |
gptkb:legislation
gptkb:United_States gptkb:Native_American_tribe |
| gptkbp:packaging |
multi-dose pens
single-use pens |
| gptkbp:population |
adults
adolescents |
| gptkbp:price |
varies by location
|
| gptkbp:provides_information_on |
obesity management guidelines
|
| gptkbp:related_to |
gptkb:Victoza
Ozempic |
| gptkbp:requires |
gptkb:theorem
|
| gptkbp:scholarships |
gptkb:stock_market_index
|
| gptkbp:side_effect |
headache
nausea vomiting diarrhea constipation |
| gptkbp:storage |
refrigerated
|
| gptkbp:suitable_for |
pregnant women
breastfeeding women people with severe kidney problems people with eating disorders people with gallbladder disease people with pancreatitis history people with severe liver problems |
| gptkbp:type_of_insurance |
may vary
|
| gptkbp:bfsParent |
gptkb:liraglutide
|
| gptkbp:bfsLayer |
6
|